Cancer Res Treat.  2021 Jul;53(3):635-640. 10.4143/crt.2021.706.

Technological Advances in Charged-Particle Therapy

• Park JM
• Kim Ji
• Wu HG

• KMID: 2518386
• DOI: http://doi.org/10.4143/crt.2021.706

Abstract

Charted-particle therapy (CPT) benefits cancer patients by localizing doses in the tumor volume while minimizing the doses delivered to normal tissue through its unique physical and biological characteristics. The world’s first CPT applied on humans was proton beam therapy (PBT), which was performed in the mid-1950s. Among heavy ions, carbon ions showed the most favorable biological characteristics for the treatment of cancer patients. Carbon ions show coincidence between the Bragg peak and maximum value of relative biological effectiveness. In addition, they show low oxygen enhancement ratios. Therefore, carbon-ion radiotherapy (CIRT) has become mainstream in the treatment of cancer patients using heavy ions. CIRT was first performed in 1977 at the Lawrence Berkeley Laboratory. The CPT technology has advanced in the intervening decades, enabling the use of rotating gantry, beam delivery with fast pencil-beam scanning, image-guided particle therapy, and intensity-modulated particle therapy. As a result, as of 2019, a total of 222,425 and 34,138 patients with cancer had been treated globally with PBT and CIRT, respectively. For more effective and efficient CPT, many groups are currently conducting further studies worldwide. This review summarizes recent technological advances that facilitate clinical use of CPT.

Keyword

Charged-particle therapy; Carbon-ion radiotherapy; Proton beam therapy

Reference

References

1. Schulz-Ertner D, Jakel O, Schlegel W. Radiation therapy with charged particles. Semin Radiat Oncol. 2006; 16:249–59.

2. Jiang GL. Particle therapy for cancers: a new weapon in radiation therapy. Front Med. 2012; 6:165–72.

3. Mohamad O, Makishima H, Kamada T. Evolution of carbon ion radiotherapy at the National Institute of Radiological Sciences in Japan. Cancers (Basel). 2018; 10:66.

4. Smith AR. Proton therapy. Phys Med Biol. 2006; 51:R491–504.

5. Particle Therapy Co-Operative Group. Facilities in operation [Internet]. Villigen: Paul Scherrer Institute;c2020. [cited 2020 Dec 15]. Available from: https://www.ptcog.ch/index.php/facilities-in-operation .

6. Bragg WH, Kleeman R. On the ionization curves of radium. Philos Mag. 1904; 8:726–38.

7. Wilson RR. Radiological use of fast protons. Radiology. 1946; 47:487–91.

8. Lawrence JH, Tobias CA, Born JL, Mc CR, Roberts JE, Anger HO, et al. Pituitary irradiation with high-energy proton beams: a preliminary report. Cancer Res. 1958; 18:121–34.

9. Larsson B, Leksell L, Rexed B, Sourander P, Mair W, Andersson B. The high-energy proton beam as a neurosurgical tool. Nature. 1958; 182:1222–3.

10. Slater JM, Archambeau JO, Miller DW, Notarus MI, Preston W, Slater JD. The proton treatment center at Loma Linda University Medical Center: rationale for and description of its development. Int J Radiat Oncol Biol Phys. 1992; 22:383–9.

11. Particle Therapy Co-Operative Group. Patient statistics [Internet]. Villigen: Paul Scherrer Institute;c2020. [cited 2020 Dec 15]. Available from: https://www.ptcog.ch/index.php/patient-statistics .

12. Castro JR. Results of heavy ion radiotherapy. Radiat Environ Biophys. 1995; 34:45–8.

13. Raju MR. Particle radiotherapy: historical developments and current status. Radiat Res. 1996; 145:391–407.

14. Brahme A. Recent advances in light ion radiation therapy. Int J Radiat Oncol Biol Phys. 2004; 58:603–16.

15. Halperin EC. Particle therapy and treatment of cancer. Lancet Oncol. 2006; 7:676–85.

16. Kamada T, Tsujii H, Blakely EA, Debus J, De Neve W, Durante M, et al. Carbon ion radiotherapy in Japan: an assessment of 20 years of clinical experience. Lancet Oncol. 2015; 16:e93–100.

17. Tsujii H, Kamada T. A review of update clinical results of carbon ion radiotherapy. Jpn J Clin Oncol. 2012; 42:670–85.

18. Kramer M, Weyrather WK, Scholz M. The increased biological effectiveness of heavy charged particles: from radiobiology to treatment planning. Technol Cancer Res Treat. 2003; 2:427–36.

19. Ando K, Kase Y. Biological characteristics of carbon-ion therapy. Int J Radiat Biol. 2009; 85:715–28.

20. Kraft G. Radiotherapy with heavy ions: radiobiology, clinical indications and experience at GSI, Darmstadt. Tumori. 1998; 84:200–4.

21. Combs SE, Jakel O, Haberer T, Debus J. Particle therapy at the Heidelberg Ion Therapy Center (HIT): integrated research-driven university-hospital-based radiation oncology service in Heidelberg, Germany. Radiother Oncol. 2010; 95:41–4.

22. Tessa CL, Berger T, Kaderka R, Schardt D, Burmeister S, Labrenz J, et al. Characterization of the secondary neutron field produced during treatment of an anthropomorphic phantom with x-rays, protons and carbon ions. Phys Med Biol. 2014; 59:2111–25.

23. Kanematsu N, Endo M, Futami Y, Kanai T, Asakura H, Oka H, et al. Treatment planning for the layer-stacking irradiation system for three-dimensional conformal heavy-ion radiotherapy. Med Phys. 2002; 29:2823–9.

24. Haberer T, Becher W, Schardt D, Kraft G. Magnetic scanning system for heavy ion therapy. Nucl Instrum Methods Phys Res A. 1993; 330:296–305.

25. Iwata Y, Kadowaki T, Uchiyama H, Fujimoto T, Takada E, Shirai T, et al. Multiple-energy operation with extended flattops at HIMAC. Nucl Instrum Methods Phys Res A. 2010; 624:33–8.

26. Furukawa T, Inaniwa T, Sato S, Shirai T, Mori S, Takeshita E, et al. Moving target irradiation with fast rescanning and gating in particle therapy. Med Phys. 2010; 37:4874–9.

27. Bhattacharyya T, Koto M, Ikawa H, Hayashi K, Hagiwara Y, Makishima H, et al. First prospective feasibility study of carbon-ion radiotherapy using compact superconducting rotating gantry. Br J Radiol. 2019; 92:20190370.

28. Haberer T, Debus J, Eickhoff H, Jakel O, Schulz-Ertner D, Weber U. The Heidelberg ion therapy center. Radiother Oncol. 2004; 73(Suppl 2):S186–90.

29. Landry G, Hua CH. Current state and future applications of radiological image guidance for particle therapy. Med Phys. 2018; 45:e1086–95.

30. Kamada T, Tsujii H, Mizoe JE, Matsuoka Y, Tsuji H, Osaka Y, et al. A horizontal CT system dedicated to heavy-ion beam treatment. Radiother Oncol. 1999; 50:235–7.

31. Oliver JA, Zeidan OA, Meeks SL, Shah AP, Pukala J, Kelly P, et al. The Mobius AIRO mobile CT for image-guided proton therapy: characterization & commissioning. J Appl Clin Med Phys. 2017; 18:130–6.

32. Mori S, Sakata Y, Hirai R, Furuichi W, Shimabukuro K, Kohno R, et al. Commissioning of a fluoroscopic-based real-time markerless tumor tracking system in a superconducting rotating gantry for carbon-ion pencil beam scanning treatment. Med Phys. 2019; 46:1561–74.

33. Favaudon V, Caplier L, Monceau V, Pouzoulet F, Sayarath M, Fouillade C, et al. Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice. Sci Transl Med. 2014; 6:245ra93.

34. Patriarca A, Fouillade C, Auger M, Martin F, Pouzoulet F, Nauraye C, et al. Experimental set-up for FLASH proton irradiation of small animals using a clinical system. Int J Radiat Oncol Biol Phys. 2018; 102:619–26.

35. Buonanno M, Grilj V, Brenner DJ. Biological effects in normal cells exposed to FLASH dose rate protons. Radiother Oncol. 2019; 139:51–5.

36. Jolly S, Owen H, Schippers M, Welsch C. Technical challenges for FLASH proton therapy. Phys Med. 2020; 78:71–82.

37. Kim JI, Park JM, Wu HG. Carbon ion therapy: a review of an advanced technology. Prog Med Phys. 2020; 31:71–80.